Acknowledgement
본 연구는 2022년도 부산대학교병원 임상연구비 지원으로 이루어졌습니다.
References
- Dong Kyu Lee, An introduction to propensity score matching methods. Anesth Pain Med 2016; 11:130-148. https://doi.org/10.17085/apm.2016.11.2.130
- Luellen JK, Shadish WR, Clark MH. Propensity scores: an introduction and experimental test. Eval Rev 2005; 29: 530-58. https://doi.org/10.1177/0193841X05275596
- Hooker, Andrew C., Mats O. Karlsson, Justin J. Wilkins, and E. Niclas Jonsson. 2020. Xpose4: Diagnostics for Nonlinear Mixed-Effect Models.
- Day AG. Why the propensity for propensity scores? Crit Care Med 2015; 43:2024-6. https://doi.org/10.1097/CCM.0000000000001175
- Tusty ten Bensel, Benjamin Gibbs & Robert Lytle. A Propensity Score Approach towards Assessing Neighborhood Risk of Parole Revocation. American Journal of Criminal Justice volume 40, pages377-398 (2015). https://doi.org/10.1007/s12103-014-9269-z
- Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv 2008; 22:31-72. https://doi.org/10.1111/j.1467-6419.2007.00527.x
- 백영민, 박인서, 「R기반 성향점수분석: 루빈 인과모혈 기반 인과추론」, 한나래 아카데미, 2021
- Dong Kyu Lee, An introduction to propensity score matching methods. Anesth Pain Med 2016; 11:130-148. https://doi.org/10.17085/apm.2016.11.2.130
- Shi, Qi, et al. "Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study." Oncotarget 8.8 (2017): 13488.
- Chiu, Sheng-Chun, et al. "Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells." BMC complementary and alternative medicine 17.1 (2017): 1-12. https://doi.org/10.1186/s12906-016-1505-2
- Tsai, Yueh-Ting, et al. "Prescription of Chinese herbal products is associated with a decreased risk of invasive breast cancer." Medicine 96.35 (2017).
- Ren, Xuejiao, et al. "Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma." Radiotherapy and Oncology 129.2 (2018): 293-299. https://doi.org/10.1016/j.radonc.2018.09.006
- Chen, Chin-Nu, Yueh-Ting Tsai, and Jung-Nien Lai. "8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association." Journal of ethnopharmacology 243 (2019): 112094.
- Xie, Gang, et al. "Aidi injection, a traditional Chinese medicine injection, could be used as an adjuvant drug to improve quality of life of cancer patients receiving chemotherapy: a propensity score matching analysis." Integrative cancer therapies 18 (2019): 1534735418810799.
- Liu, Chien-Ting, et al. "Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study." Trials 20.1 (2019): 1-8. https://doi.org/10.1186/s13063-018-3101-x
- Chang, Chia-Chen, et al. "Conventional Western treatment associated with Chinese herbal medicine ameliorates the incidence of head and neck cancer among patients with esophageal cancer." Integrative cancer therapies 18 (2019): 1534735419834353.
- Liu, Yao, et al. "Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3-4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment." The Journal of Alternative and Complementary Medicine 26.10 (2020): 956-965. https://doi.org/10.1089/acm.2019.0334
- Lin, Tsai-Hui, et al. "Conventional western treatment combined with Chinese herbal medicine alleviates the progressive risk of lung cancer in patients with chronic obstructive pulmonary disease: A nationwide retrospective cohort study." Frontiers in pharmacology 10 (2019): 987.
- Chen, Hsing-Yu, et al. "Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study." BMC complementary and alternative medicine 19.1 (2019): 1-13. https://doi.org/10.1186/s12906-018-2420-5
- Su-Tong, Liu, et al. "The effect of long-term traditional Chinese medicine treatment on disease-free survival of postoperative stage I-III lung cancer patients: a retrospective cohort study." Traditional Medicine Research 4.2 (2019): 91.
- Shi, Ke, et al. "Adjuvant Fuzheng Huayu capsule reduces the incidence of hepatocellular carcinoma in patients with hepatitis B-caused cirrhosis." Evidence-Based Complementary and Alternative Medicine 2020 (2020).
- Huang, Chia-Yu, et al. "Chinese herbal medicine is helpful for survival improvement in patients with multiple myeloma in Taiwan: A nationwide retrospective matched-cohort study." Integrative Cancer Therapies 19 (2020): 1534735420943280.
- Zhao, He-tong, et al. "Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study." Journal of Integrative Medicine 18.4 (2020): 319-325. https://doi.org/10.1016/j.joim.2020.05.003
- Zhang, Zhen, et al. "Data Mining and System Pharmacology to Elucidate the Efficiency and Mechanism of Chinese Medicine in Treating Primary Liver Cancer." (2020).
- Liao, Yu-Pei, et al. "Effects and relative factors of adjunctive Chinese medicine therapy on survival of hepatocellular carcinoma patients: a retrospective cohort study in taiwan." Integrative Cancer Therapies 19 (2020): 1534735420915275.
- Wang, Yuli, et al. "The effect of long-term traditional Chinese medicine treatment on survival time of colorectal cancer based on propensity score matching: a retrospective cohort study." Evidence-Based Complementary and Alternative Medicine 2020 (2020).
- Shi, Qi, et al. "A Four Ingredients Chinese Herbal Formula, Decreases the Metastatic Recurrence of Postoperative Patients With Stage II-III Colorectal Cancer." (2021).
- Hou, Chao, et al. "Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study." Integrative cancer therapies 20 (2021): 15347354211058464.
- Xu, Li-Li, et al. "The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching." Evidence-Based Complementary and Alternative Medicine 2021 (2021).
- Shih, Wei-Tai, et al. "Traditional Chinese medicine enhances survival in patients with gastric cancer after surgery and adjuvant chemotherapy in Taiwan: a nationwide matched cohort study." Evidence-Based Complementary and Alternative Medicine (2021).
- Yang, Shu-Yi, et al. "Association of Chinese herbal medicine use with the depression risk among the long-term breast cancer survivors: A longitudinal follow-up study." Frontiers in Psychology (2022).
- Tan, Ying, et al. "Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response." Frontiers in pharmacology 13 (2022).
- Hou, Zong, et al. "Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer." Journal of Ethnopharmacology 292 (2022): 115222.
- Hou, Jie, et al. "Effects of Traditional Chinese Medicine Adjuvant Therapy on the Survival of Patients with Primary Liver Cancer." Evidence-Based Complementary and Alternative Medicine 2022 (2022).
- Luo, Shaoju, and Hao Hu. "Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysis." Journal of Ethnopharmacology (2022): 115774.
- Li, Honglin, et al. "Traditional Chinese Medicine Decoctions Improve Longevity Following Diagnosis with Stage IV Esophageal Squamous Cell Carcinoma: A Retrospective Analysis." International Journal of General Medicine 15 (2022): 1665.
- Tusty ten Bensel, Benjamin Gibbs & Robert Lytle. A Propensity Score Approach towards Assessing Neighborhood Risk of Parole Revocation. American Journal of Criminal Justice volume 40, pages377-398 (2015). https://doi.org/10.1007/s12103-014-9269-z
- King, Gary, and Richard Nielsen. "Why propensity scores should not be used for matching: Supplementary appendix." (2016).
- 박봉기, et al. "국내에 보고된 한국 한의학의 암치료 임상연구에 대한 계통적 고찰." 대한한방내과학회지 29.4 (2008): 1061-1074.